OBJECTIVE: Inhaled corticosteroids (ICSs) are the most effective medications available for
patients with persistent asthma of all severities and currently are recommended as the …

Inhaled corticosteroids (ICSs) are recommended for patients with asthma who use a short-
acting 2-adrenergic agonist more than twice weekly—a key indicator of disease …

Background: Although inhaled corticosteroids (ICS) are commonly used in the treatment of
persistent asthma, the relationship between dose and clinical response remains unclear …

Abstract Background Inhaled corticosteroids (ICSs) are the mainstay of daily controller
treatment for persistent and uncontrolled asthma. However, many clinicians are wary of ICSs …

Inhaled corticosteroids (ICS) have become the mainstay of therapy in chronic childhood
asthma. Despite the long history and the documented efficacy of these drugs in controlling …

OBJECTIVE: To assess the dose-response relationship (benefits and harms) of inhaled
corticosteroids (ICSs) in children with persistent asthma. METHODS: We conducted a …

Asthma is a chronic inflammatory disease characterized by symptoms of cough, dyspnea,
chest tightness, and wheeze. Inhaled corticosteroids (ICS) have been recommended as …

Asthma is the most common chronic illness among children, and inhaled corticosteroids
(ICS) are the most effective long‐term therapy available for suppressing airway inflammation …

Inhaled corticosteroids are established as the mainstay of maintenance therapy for chronic
asthma. However, there remains some debate regarding the safety of long-term use of these …

OBJECTIVE: To review the efficacy and safety of inhaled corticosteroids (ICSs) when used to
reduce daily oral corticosteroid (OCS) requirements in patients with severe persistent …